Lucile Packard Children's Hospital and Stanford Clinics
Stanford, California, 94305, United States
NCT Number: NCT02162706
Cortisol is a hormone critical for survival in times of stress. Currently most measurements are done with blood samples. The hypothesis of this study is cortisol measured from saliva using mass spectrometry can be used to replace measurements by blood.
Looking for future studies?
Notify Me3 year–17 year
All sexes
Observational
Stanford, California, 94305, United States
Cortisol levels change depending on the time of day. Salivary samples were collected from health controls at bedtime, midnight and first morning waking on two consecutive nights and salivary cortisol levels were measured using mass spectrometry. In a patients with possible endocrine disorders who were going through an adrenocortiotropin stimulation test for adrenal insufficiency, salivary cortisol was measured prior to giving cosyntropin and 30-40 minutes after cosyntropin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: All collections are done within 48 hours
Stanford University
Other
Pilot Study of Salivary Cortisol Measurements by Mass Spectrometry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07457255
Childhood Brain Tumors, Endocrine Disorders
Ljubljana, Slovenia
View Trial DetailsNCT07727356
ACTH Syndrome, Ectopic, Adrenal Gland Diseases
Zurich, Switzerland
View Trial DetailsNCT06326853
Acromegaly, Adiposity
View Trial DetailsNCT07716579
Brain Diseases, Brain Neoplasms
Ljubljana, Slovenia
View Trial Details